Outcomes among racial and ethnic minority patients with advanced cancers in phase 1 trials: a meta-analysis (vol 7, e2421485, 2024)

被引:0
|
作者
Goel, Sanjay
Negassa, Abdissa
Ghalib, Mohammad H.
Chaudhary, Imran
Desai, Kavita
Shah, Umang
Swami, Umang
Cohen, Bruce
Maitra, Radhashree
Mani, Sridhar
机构
关键词
D O I
10.1001/jamanetworkopen.2024.33744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 35 条
  • [21] Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials
    Kunutsor, Setor K.
    Khunti, Kamlesh
    Seidu, Samuel
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2024, 117 (08) : 267 - 283
  • [22] HbA1c reduction and weight-loss outcomes: a systematic review and meta-analysis of community-based intervention trials among patients with type 2 diabetes mellitus
    Pamungkas, Rian Adi
    Chamroonsawasdi, Kanittha
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2019, 39 (02) : 394 - 407
  • [23] Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials
    Rivera, Frederick Berro
    Cruz, Linnaeus Louisse A.
    Magalong, John Vincent
    Ruyeras, Jade Monica Marie J.
    Aparece, John Paul
    Bantayan, Nathan Ross B.
    Lara-Breitinger, Kyla
    Gulati, Martha
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 18
  • [24] HbA1c reduction and weight-loss outcomes: a systematic review and meta-analysis of community-based intervention trials among patients with type 2 diabetes mellitus
    Rian Adi Pamungkas
    Kanittha Chamroonsawasdi
    International Journal of Diabetes in Developing Countries, 2019, 39 : 394 - 407
  • [25] Predictive value of vascular endothelial growth factor A (VEGF-A) for bevacizumab-based treatments across advanced cancers: a meta-analysis based on eight phase III randomized control trials involving 4,523 patients
    Tang, S.
    Zhang, Y.
    Liang, W.
    He, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials (vol 90, pg 313, 2018)
    Liu, Xiangying
    Hang, Yongfu
    Shen, Lei
    Yang, Jing
    Zhou, Ling
    Sha, Wengang
    Lu, Guoyuan
    CLINICAL NEPHROLOGY, 2019, 91 (01) : 64 - 64
  • [27] Comparing clinical outcomes of immediate implant placement with early implant placement in healthy adult patients requiring single-tooth replacement in the aesthetic zone: a systematic review and meta-analysis of randomised controlled trials (Vol 24, 93, 2024)
    Asghar, Aisha Maria
    Sadaf, Durre
    Ahmad, Muhammad Zubair
    Jackson, Guy
    Bonsor, Stephen J.
    EVIDENCE-BASED DENTISTRY, 2024,
  • [28] PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS
    Einhorn, Daniel
    Handelsman, Yehuda
    Bode, Bruce W.
    Endahl, Lars A.
    Mersebach, Henriette
    King, Allen B.
    ENDOCRINE PRACTICE, 2015, 21 (08) : 917 - 926
  • [29] META-ANALYSIS OF RANDOMIZED PHASE II/III TRIALS ADDING BEVACIZUMAB TO PLATIN-BASED CHEMOTHERAPY AS 1ST-LINE TREATMENT IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Soria, J.
    Mauguen, A.
    Reck, M.
    Sandler, A.
    Nishio, M.
    Johnson, D.
    Besse, B.
    Pignon, J. P.
    ANNALS OF ONCOLOGY, 2010, 21 : 147 - 147
  • [30] Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
    Lee, Mei-Chuan
    Hua, Yi-Ming
    Yang, Chun-Ting
    Kuo, Fang-Hsiu
    Chang, Wei-Ting
    Tang, Hsin-Ju
    Toh, Han Siong
    Lin, Yu-Min
    Chen, Sih-Yao
    Chang, Hung-Yu
    Liao, Chia-Te
    MEDICINE, 2022, 101 (51) : E32489